BPC-157 is typically administered subcutaneously, near the site of injury, at dosages ranging from 200 to 500 mcg daily
It was a randomized, double-blind, placebo-controlled trial that enrolled 6,068 subjects with type 2 diabetes and a recent acute coronary syndrome (ACS) event
Kind of iffy about a reorder
In 2026 the FDA reviewed the status of several compounded peptides, and the regulatory picture is still evolving, which is exactly why sourcing and provider supervision matter
Key points 2,500 years ago in Greece, Hippocrates, the Father of Medicine, said, All diseases begin in the gut. GLP-1 agonist meds like Ozempic reduce food, alcohol and cocaine intake and may improve behavioral addictions
Hsieh et al